Israel Parkinson is a unique initiative of The Aufzien Family Center for Prevention and Treatment of Parkinson's Disease at Tel-Aviv University, developed to better understand the early stages (prodromal) of Parkinson's Disease (PD) in Israel and to detect persons who might benefit from early detection and intervention.
By participating in this project you will join a global initiative to identify subjects at risk to PD and who will be targeted in future clinical trials, aimed at delaying or preventing PD.
Participants will be followed longitudinally and a sub-group will be invited for more detailed assessments and possibly will take part in future clinical trials with technologies aiming to stop the progress of PD at its early stages. All tests and participation in the project are free of charge and under medical confidentiality.
Join us now and you will support:
✓ The establishment of a unique Israeli cohort
✓ Identification of early markers for PD
✓ Investigating risk factors for PD
✓ Research about motor and non-motor features of PD in its early stages
The Aufzien Family Center for the Prevention and Treatment of Parkinson's Disease (APPD) has been established by a generous donation from the Aufzien Family to promote and enhance research towards better treatment and prevention of Parkinson's Disease. The APPD is an academic Center at the Faculty of Medicine and Sagol School of Neuroscience at Tel-Aviv University, which serves as a hub for innovative translational research in Parkinson's Disease.
The Center has a grant program and educational activities to support cutting-edge research towards better treatment and prevention, or slowing down of Parkinson's Disease progression. The Center holds monthly seminars, annual international symposiums and active student exchange programs and promotes Parkinson’s research conducted on campus and at affiliated hospitals, working toward the development of novel drugs, therapies and diagnostic technologies for Parkinson’s Disease.
Israel Parkinson is led by a Steering Committee, composed of the Israeli Movement Disorders Society steering committee members (IMDS, part of the Israel Neurological Association), who are leading experts in the field of movement disorders and the directors of the Aufzien Center. The Steering Committee provides strategic direction, support, guidance and oversight of the Israel Parkinson Initiative.
The current Chairman of the Israel Parkinson Steering Committee is Prof. Nir Giladi.
Members of the Steering Committee
Nir Giladi, M.D., is a renowned leader in the field of movement disorders, Full Professor at the Sackler Faculty of Medicine at Tel-Aviv University and chairman of the Neurological Institute at the Tel Aviv Sourasky Medical Center. Giladi and his clinical and research groups are focused on two major goals: striving to give the best neurological care possible to the patients in their care and to finding a cure for Parkinson's Disease.
Karen B. Avraham, Ph.D., is Vice Dean and Full Professor at the Sackler Faculty of Medicine and holds the Drs. Sarah and Felix Dumont Chair for Research of Hearing Disorders. She performs research on the genomics of deafness and neurodevelopmental disorders at the Department of Human Molecular Genetics and Biochemistry and is a member of the Sagol School of Neuroscience and the Safra Center for Bioinformatics.